Dosimetric framework for therapeutic alpha-particle emitters.
Alpha-particle emitters are currently being considered for the treatment of metastatic disease. However, the dosimetry of alpha-particle emitters is a challenge because the dimensions of subcellular targets (e.g., the cell nucleus) are of the same order of magnitude as the range of the particle. Hence, a single dose value is often not representative of the dose delivered to a cell population. Here, we propose a dosimetry system that combines the calculational ease of the Medical Internal Radiation Dosimetry (MIRD) system with the additional information provided by microdosimetry.


METHODS
Beginning with the microdosimetric, single-event specific-energy spectrum, we derived expressions for the first and second moments. Using the MIRD S-factor along with these moments, we determined not only the mean absorbed dose but also the s.d. and the fraction of cells receiving zero (or any number of) hits.


RESULTS
Using the formalism developed here, we have generated tables for a simple example to demonstrate the use of this method.


CONCLUSIONS
We have developed a formalism for the rapid determination of not only the mean absorbed dose but also the s.d. and fraction of cells receiving zero hits. These parameters are potentially useful in analyzing the biological outcome for cells exposed to alpha-particle irradiation.
Roeske
J C
JC
Department of Radiation, The University of Chicago, Illinois 60637, USA.
Stinchcomb
T G
TG
D000512:Alpha Particles / Q000627:therapeutic use*; D006801:Humans; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy